Cytokine-induced stimulation of p38 mitogen activated protein kinase (MAPK) has been shown to influence behaviorally-relevant pathophysiologic pathways including monoamine neurotransmission and neuroendocrine function and thus may contribute to behavioral changes that occur during chronic administration of the innate immune cytokine, interferon (IFN)-alpha. Accordingly, in the current study, phosphorylation (activation) of intracellular p38 MAPK in peripheral blood lymphocytes was analyzed by flow cytometry every 2 h for 12 h following the initial injection of IFN-alpha in eleven patients with chronic hepatitis C. Hourly assessments of plasma concentrations of adrenocorticotropic hormone, cortisol and interleukin-6 were also obtained. Symptoms of depression and fatigue were measured at baseline and after 4 and 12 weeks of IFN-alpha treatment. Acute administration of IFN-alpha significantly increased the percentage of lymphocytes staining positive for intracellular phosphorylated p38 (pp38). IFN-alpha-induced increases in p-p38 were significantly greater in patients that developed clinically significant depressive symptoms [Montgomery-Asberg Depression Rating Scale (MADRS) score P 15] during the first 12 weeks of IFN-alpha treatment. Increases in the percentage of p-p38-positive lymphocytes following the first IFN-alpha injection also highly correlated with depression severity at weeks 4 (r = 0.85, p = 0.001) and 12 (r = 0.70, p = 0.018). Similar relationships were observed for fatigue. Examination of relationships between p-p38 induction and factors previously reported to predict IFNalpha-induced depressive symptoms revealed strong associations of p-p38 with baseline MADRS (r = 0.82, p = 0.002) and cortisol responses to the initial injection of IFN-alpha (r = 0.91, p = 0.000). Taken together, these findings indicate that sensitivity of p38 MAPK signaling pathways to immune stimulation is associated with depressive symptoms during chronic IFN-alpha treatment.
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Introduction
Activation of the innate immune system has been shown to produce behavioral alterations that are mediated in part by changes in monoamine metabolism and the hypothalamic-pituitary-adrenal (HPA) axis (Dantzer et al., 2008; Miller et al., 2009) . For example, administration of the innate immune cytokine, interferon (IFN)-alpha, for infectious diseases and cancer induces high rates of depression and fatigue, and alters both monoamines and HPA axis function. More specifically, IFN-alpha increases cerebrospinal fluid (CSF) cytokines which negatively correlate with CSF concentrations of the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), that, in turn, correlate with depression (Raison et al., 2009 ). In addition, polymorphisms in the serotonin transporter have been associated with IFN-alpha-induced depression severity (Bull et al., 2009; Lotrich et al., 2009) . IFN-alpha has also been shown to inhibit glucocorticoid receptor (GR) function and lead to flattening of the diurnal cortisol curve, which correlates with depression and fatigue (Hu et al., 2009; Raison et al., 2010a) .
One mechanism by which innate immune cytokines such as IFN-alpha may affect monoamine metabolism and neuroendocrine function is through activation of p38 mitogen activated protein kinase (MAPK). Activation of p38 MAPK has been shown to increase the activity and expression of the serotonin transporter in vitro and in vivo (Zhu et al., 2006 (Zhu et al., , 2010 . In addition, increased basal p38 MAPK activation in peripheral blood mononuclear cells of abused monkeys was found to correlate with decreased CSF concentrations of 5-HIAA (Sanchez et al., 2007) . Cytokine-induced
